Novo Nordisk ousts CEO amid increasing competition in weight-loss market
16.05.2025, 19:00
Novo Nordisk has announced the unexpected departure of its CEO, Lars Fruergaard Jørgensen, following a significant decline in the company’s stock price and growing competition in the obesity drug market, particularly from rival Eli Lilly. The decision marks a notable shift for the company, which...